Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

Update on compliance with standards for sterile compounding with emphasis on USP chapters <797> and <800> (Technicians)


Update on compliance with standards for sterile compounding
with emphasis on USP chapters <797> and <800>
 
Course Description:  This is a management level course for individuals who oversee sterile compounding facilities and are responsible for ensuring compliance with current minimum practice standards. The course will focus on the practical application of the “musts” and the “shoulds” from USP chapters <797> and <800> through the use of tools and best practice recommendations.
 
Target Audience:  Pharmacists, pharmacy technicians, and other individuals who are practicing and/or responsible for compliance with sterile compounding standards.
 
Location of Event:  The program will be offered at the Aseptic Compounding Experience (ACE) Lab, located at 715 Sumter Street, University of South Carolina College of Pharmacy Campus in Columbia, SC.
 
Program Faculty:
  • Richard Capps, PharmD, Pharmacy Manager at Oconee Memorial Hospital in Seneca, SC
  • Shay Garrison, RPh, MPH, Pharmacist Specialist at Palmetto Health Richland Hospital in Columbia, SC (specializing in sterile compounding, USP <797>, and USP <800>)
  • Bill Mixon, RPh, MS, FIACP, FACA, Former Owner/Manager of The Compounding Pharmacy (a Pharmacy Compounding Accreditation Board (PCAB) accredited compounding-only pharmacy) in Hickory, NC
  • Eric Sparks, President of BioTech Balancing
        Disclosure:  Faculty, planners, reviewers, staff, and CPE committee report no financial or personal relationship with
       any commercial interest producing, marketing, reselling, or distributing a product or service that appears in this program. 
       There is no commercial support for this program.
 
Course Requirements:   It is a strong recommendation that attendees read and review USP chapters <797> and <800> prior to attending the course.  The participant must physically be able to stand for a minimum of 2 hours.  Participant must also have full range of motion to complete physical tasks required in the compounding process. 
 
Continuing Education Credit Requirements:  To obtain continuing education credit, participants must sign in upon arrival, have attendance verified, attend the program in its entirety, and fully complete the associated online evaluation.  Failure to complete the evaluation within 30 days of attendance may result in loss of credit.  The NABP CPE Monitor will not accept credit submitted greater than 60 days from the date of attendance.

Program Schedule:


 
Program Registration Fees, Cancellation and Refund Policies
 
Registration Fees:  Pharmacists/Technicians: $750
*Please note that fees will show as "Learning Express" on your credit card statement.*
Registration is limited and will be taken on a first come first serve basis. Fee includes on-site training and continuing education credit.  Breakfast, lunch, and morning and afternoon snacks are provided.   Participants will be responsible for their own dinner, travel, and hotel accomodations if required.
 
Cancellation Policy: 
  • Cancellations received in writing at least 30 days prior to program date via letter or email to CE@cop.sc.edu will receive a full refund minus a $200 cancellation fee.
  • USC COP reserves the right to cancel the entire program.  In the event of a conference cancellation, each participant will be notified via phone and/or email at least 14 days prior to the program and a full tuition refund will be made.
  • In the event of inclement weather, the decision to cancel a course will be made no later than 9:00 am Eastern time the day before the program.
Registration transfers:
  • Individuals attending the course in place of the registered individual will be honored as long as the request is made in advance of the registration deadline, which is 14 days prior to the event. 
Refunds:
  • Refund requests are subject to a $200.00 cancellation fee and must be received 30 days prior to the start of the live component. All registration cancellations must be submitted in writing or by e-mail to the Continuing Education Department at the following address:  University of South Carolina College of Pharmacy Continuing Education, 715 Sumter Street, Room 314C, Columbia, SC  29208, Email: CE@cop.sc.edu
  • Registrants may receive 100% of the program registration fees, less the $200.00 cancellation fee up to 30 days prior to start date of the live component. No refunds are offered for cancellations fewer than 30 days prior to the start date of the live component or for no shows.
RSVP Information and cut-off date:  
 
  • Registration will be accepted until 7 days prior to the start of the program or until capacity has been reached.

 
 

Date: Feb 23, 2018 08:00 AM - Feb 24, 2018 05:30 PM

Fee

$750.00

CE Hours

16.00

CE Units

1.600

Registration closes on Feb 16, 2018 11:55 PM

Activity Type

  • Practice Based

Target Audience(s)

  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

Participants must sign in upon arrival, have attendance verified, attend the program in its entirety, and fully complete the associated online evaluation.  Failure to complete the evaluation within 30 days of attendance may result in loss of credit.  The NABP CPE Monitor will not accept credit submitted greater than 60 days from the date of attendance.
 
Participants must update their accounts to properly reflect their month and day of birth and their correct NABP E-Id.  Failure to do so may result in loss of credit.  Registration with a proper disclosure of your NABP E-Id is a requirement for receiving Continuing Pharmacy Education.  To register with or look up your NABP E-Id, please click on the CPE Monitor logo below to be directed to their site.

 

 

 

   

At the completion of this activity, the pharmacy technician will be able to:
  1. Develop training for compounding personnel based on the competencies, documentation, and requirements outlined in USP <797> and <800>.
  2. Adhere to the minimum standards operating procedures (SOPs) required by USP <797> and USP <800>.
  3. Employ performance improvement, quality assurance (QA) and quality control (QC) methods.
  4. Evaluate the operation and function of primary and secondary engineering controls and assess how they work together to ensure a proper environment for sterile compounding.
  5. Implement environmental monitoring and an environmental sampling plan.
  6. Analyze environmental sampling results to identify potential issues related to cleaning activities and other sources of contamination.
  7. Analyze material handling and personnel processes in a cleanroom in order to minimize particle generation and risk of contamination to the cleanroom environment and sterile compounds.
  8. Evaluate personnel performing hand hygiene, garbing, and gloved fingertip sampling according to USP <797> and USP <800> requirements.
  9. Develop and implement a cleaning program that complies with USP <797> and USP <800> requirements.
  10. Analyze a certification report to identify key components, to effectively utilize the information to maintain the cleanroom environment, and to ensure the PECs and SECs are functioning as designed.
  11. Differentiate between the three risk levels for sterile compounding.
  12. Evaluate the limitations of the three primary methods of sterilization for high risk compounding.
  13. Demonstrate proper use and limitations of bubble point testing equipment.
  14. Interpret key components of a Certificate of Analysis.
  15. Develop a process for quality release testing, batch testing, and assigning a beyond use date for sterile compounds.
  16. Examine the requirements of USP <800> related to containment, personal protective equipment (PPE), and cleaning/deactivation/decontamination of PECs and SECs used for compounding hazardous drugs.
  17. Evaluate the types of containment primary engineering controls that are acceptable for sterile hazardous drug compounding as defined in USP Chapter 800.
  18. Assess the facility requirements for compounding sterile hazardous drugs as defined in USP Chapter 800.
  19. Develop and implement the components of a Hazard Communication Plan.
  20. Conduct an Assessment of Risk.
  21. Educate others on resources for identification of hazardous drugs and their exposure risks.
  22. Demonstrate spill management and disposal of hazardous drug waste.
  23. Conduct medical surveillance.
  24. Implement environmental controls for minimizing exposure to hazardous drugs: storage, general handling, labeling and transport.
  25. Develop strategies for managing drug shortages and the challenges they pose to sterile compounding.

Speaker(s)/Author(s)

Eric Sparks
President, BioTech Balancing

Richard Capps, PharmD
Pharmacy Manager, Oconee Memorial Hospital

Shay Garrison, RPh, MPH
Pharmacist Specialist, Palmetto Health Richland

William Mixon, RPh, MS, FIACP, FACA
Former Owner/Manager, The Compounding Pharmacy

Activity Number

0062-0000-18-009-L07-T
Date: 02/23/18 08:00 AM - 02/24/18 05:30 PM

CE Hours

16.00